TENEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tenex, and when can generic versions of Tenex launch?
Tenex is a drug marketed by Promius Pharma and is included in one NDA.
The generic ingredient in TENEX is guanfacine hydrochloride. There are seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenex
A generic version of TENEX was approved as guanfacine hydrochloride by WATSON LABS on October 17th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENEX?
- What are the global sales for TENEX?
- What is Average Wholesale Price for TENEX?
Summary for TENEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Patent Applications: | 823 |
| What excipients (inactive ingredients) are in TENEX? | TENEX excipients list |
| DailyMed Link: | TENEX at DailyMed |
US Patents and Regulatory Information for TENEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-001 | Oct 27, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-002 | Nov 7, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-003 | Nov 7, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TENEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-001 | Oct 27, 1986 | ⤷ Sign Up | ⤷ Sign Up |
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-003 | Nov 7, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-002 | Nov 7, 1988 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TENEX
See the table below for patents covering TENEX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Sweden | 335723 | ⤷ Sign Up | |
| France | 1584670 | ⤷ Sign Up | |
| Switzerland | 479559 | Verfahren zur Herstellung von Acylguanidinen | ⤷ Sign Up |
| Netherlands | 6812271 | ⤷ Sign Up | |
| Belgium | 721328 | Acétyl-guanidines et leur préparations | ⤷ Sign Up |
| United Kingdom | 1235723 | ⤷ Sign Up | |
| Denmark | 120698 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
